Form 4 holding
Director
NRX Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 43,093
- Estimated value
- $13,785
- Report date
- 24 May 2021
- Price
- $0.3199
- Ownership
- Direct
Daniel Troy - Director at NRX Pharmaceuticals, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- NRXP on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Daniel Troy since 13 Sep 2025
Reported holdings for Daniel Troy in NRX Pharmaceuticals, Inc.
Form 4 holding
Director
NRX Pharmaceuticals, Inc.
- Security class
- Employee Stock Option (Right to buy)
- Shares / value
- 65,437
- Estimated value
- $13,087
- Report date
- 24 May 2021
- Price
- $0.2000
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Daniel Troy in NRX Pharmaceuticals, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.